Page 93 - 2021 Taiwan Food and Drug Administration Annual Report

November November 3 Organized the “Imported and Domestic Beef Safety
Seminar”, where domestic experts and scholars in the
November 10, 12, fields of veterinary medicine, zoology, neuromedicine,
17 and 19 animal epidemiology, public health, food safety and law
shared international safe trade standards for beef and
November 17 LPSOHPHQWDWLRQ SUDFWLFHV RI GLႇHUHQW FRXQWULHV

November 18 Participated in the USP-APEC Center of Excellence for
November 30 Advanced Therapies Pilot Virtual Workshop, “Starting
and Raw Materials for Advanced Therapies”, to discuss
December December 7 materials used in emerging therapies, selection of
to December 9 controversial biological materials, risks of using biological
December 9 materials, and biological drugs, etc., to enhance the
December 15 review capacity of drug reviewers from regulatory
December 15 agencies in various countries.
to December 17
Organized the Experience Sharing Symposium of “Japan
Introducing the HACCP”, and invited Director Hiroshi
Asakura of the National Institute of Health Sciences to
share the current status of HACCP implementation in
Japan through video conferencing. By understanding
Japan’s policy planning and implementation, we were
able to formulate the policy direction of expanding the
+$&&3 LQ WKH GRPHVWLF IRRG LQGXVWU\ IXUWKHU UH¿QLQJ WKH
country’s food safety management policies.

+HOG D SROLF\ EULH¿QJ VHVVLRQ RQ WKH ³/DEHOLQJ RI 2ULJLQ
of Pork Raw Materials”, and invited chain catering and
sellers related to pork to communicate the labeling
regulations.

Held the “Symposium on Labeling Requirements for
Pork Product Importers” to explain the requirements for
the labeling of origin of pork raw materials and relevant
examples, and provided templates for labels and stickers
of the origin of pork raw materials and the declaration for
imported pork.

TFDA became a formal member in the 14th International
Cooperation on Cosmetics Regulation (ICCR) annual
online meeting.

Co-organized the “2020 Drug Safety Surveillance
Seminar - Development of Drug Safety Surveillance
Under the COVID-19 Pandemic” with the Taiwan Drug
Relief Foundation.

Organized the 2020 “Ministry of Health and Welfare -
0LQLVWU\ RI (FRQRPLF $ႇDLUV 3KDUPDFHXWLFDO 7HFKQRORJ\
Research and Development Award” ceremony
to encourage the development of the domestic
biotechnology industry.

Participated in the online Pharmaceuticals and Medical
Devices Agency (PMDA) - Asia Training Center
(ATC) Multi-Regional Clinical Trial Seminar “PMDA-
ATC Pharmaceuticals Review Webinar 2020”, where
pharmaceutical administration inspectors shared their
experience in drug review.

91